CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region

Authors: Paula Ferreira Salles, Daiana Souza Perce-da-Silva, Atila Duque Rossi, Luisa Riehl Raposo, Aina Danaisa Ramirez Ramirez, Otílio Machado Pereira Bastos, Lilian Rose Pratt-Riccio, Gustavo Capatti Cassiano, Andrea Regina Souza Baptista, Cynthia Chester Cardoso, Dalma Maria Banic, Ricardo Luiz Dantas Machado
Publication Year: 2021
Journal: Frontiers in Pharmacology, 12, art 542342
Link: https://doi.org/10.3389/fphar.2021.542342

ABSTRACT Genetic variability was linked with individual responses to treatment and susceptibility to malaria by Plasmodium vivax. Polymorphisms in the CYP2D6 gene may modulate enzyme level and activity, thereby affecting individual responses to pharmacological treatment. The aim of the study was to investigate whether or not CYP2D6 single nucleotide polymorphisms rs1065852, rs38920-97, rs16947 and rs28371725 are unequally distributed […]
Read More

QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities

Authors: Lima MNN, Melo-Filho CC, Cassiano GC, Neves BJ, Alves VM, Braga RC, Cravo P, Muratov EN, Calit J, Bargieri DY, Costa FT, Andrade CH
Publication Year: 2018
Journal: Frontiers in Pharmacology
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845645/%20

Malaria is a life-threatening infectious disease caused by parasites of the genus Plasmodium, affecting more than 200 million people worldwide every year and leading to about a half million deaths. Malaria parasites of humans have evolved resistance to all current antimalarial drugs, urging for the discovery of new effective compounds. Given that the inhibition of […]
Read More

Menthol and Menthone Associated with Acetylsalicylic Acid and Their Relation to the Hepatic Fibrosis in Schistosoma mansoni Infected Mice

Authors: Feitosa KA, Zaia MG, Rodrigues V, Castro CA, Correia RO, Pinto FG, Rossi KNZP, Avó LRS, Afonso A, Anibal FF
Publication Year: 2018
Journal: Frontiers in Pharmacology
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778335/

Schistosomiasis is an important parasitic disease caused by Schistosoma mansoni, an intravascular trematode. Schistosomiasis treatment is limited to just one drug, Praziquantel (PZQ). Thus, studies on new antischistosomal compounds are of fundamental importance to disease control. Here we report on the effects of Mentha piperita L. compounds – menthol and menthone – in association with acetylsalicylic acid (ASA) […]
Read More

Anti-inflammatory properties of menthol and menthone in Schistosoma mansoni infection

Authors: Afonso A, Allegretti SM, Anibal FF, Cagnazzo TDO, Faccioli LH, Feitosa KA, Soares EG, Zaia MG
Publication Year: 2016
Journal: Frontiers in Pharmacology
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911957/

Schistosomiasis is a parasitic disease caused by several species of trematode worms and it is believed that more than 261 million people are affected worldwide. New drug development has become essential because there is a risk of the parasite becoming resistant to Praziquantel, the only drug available for this infection. This study evaluated parasitological, immunological […]
Read More

CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region

QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities

Menthol and Menthone Associated with Acetylsalicylic Acid and Their Relation to the Hepatic Fibrosis in Schistosoma mansoni Infected Mice

Anti-inflammatory properties of menthol and menthone in Schistosoma mansoni infection

About GHTM

Contacts

Map